| INTRODUCTION
IgA vasculitis (IgAV), also known as Henoch-Schönlein purpura (HSP), is the most common childhood vasculitis that predominantly affects small vessels, and is characterized by purpura, abdominal pain, arthritis and renal involvement. 1 Although the exact etiology of IgAV remains unknown, environmental factors, including infectious agents, drugs and vaccinations, have been implicated as possible triggers of IgAV. The main cutaneous finding of IgAV is palpable purpura. Skin biopsy shows leukocytoclastic vasculitis (LCV) of the small vessels in the upper layer of the dermis with IgA and C3 deposition in the affected vessel walls. 1 As with other skin manifestations of IgAV, blistering eruptions sometimes develop in adult patients, but they are rare in children. 2 Here, we describe a child with IgAV who developed blistering eruptions with tissue eosinophilia.
| CASE REPORT
A 5-year-old girl presented to us with vesicular purpura, abdominal pain, and tarry stool. She had been suffering from erythematous papules for 2 months and consulted the local dermatology clinic 5 days before admission to our hospital.
She was suspected to have folliculitis, and treatment with oral cefdinir was initiated. She developed vesicular purpura and abdominal pain 1 day after initiation of cefdinir treatment. Because these symptoms and signs worsened and tarry stool developed, she was referred to our hospital. She had never been prescribed cefdinir before, although she had taken cefditoren pivoxil four times before without any adverse events. She had a history of bronchial asthma attacks from 2 years of age. Her maternal uncle had a past history of IgAV. Physical examination revealed vesicular purpura with surrounding erythematous induration (Figures 1 and 2 ) on the arms, legs, left cheek and left ear, and abdominal pain and tenderness in the periumbilical area. Her blood pressure, pulse rate, and temperature were normal.
Laboratory studies revealed normal values for the following: complete blood cell count, platelet count, activated partial thromboplastin time, prothrombin time, electrolytes, liver enzymes, blood urea nitrogen, creatinine, urinalysis, antistreptolysin O, IgG, IgA, IgM, C3, C4, and CH50. Tests for hepatitis B surface antigen, hepatitis C antibody, antinuclear antibody, myeloperoxidase-antineutrophil cytoplasmic antibodies (ANCA), and proteinase 3-ANCA were negative. Her serum eosinophil count was 153/μL (2%, normal range 0.5%-6.6%). Her C-reactive protein level (1.20 mg/dL, normal <0.31 mg/dL) and erythrocyte sedimentation rate (21 mm/1 h, normal <10 mm/1 h) were slightly increased, while her factor XIII activity was decreased (74%, normal >90%).
Skin punch biopsy of a fresh vesicular purpuric lesion showed epidermal vesicles with neutrophil infiltration (Figure 2A ), and LCV of the small vessels with perivascular eosinophil infiltration in all the layers of the dermis ( Figure 2B ). The tissue eosinophilia ratio (the mean eosinophil score/the mean inflammatory density score), which was reported in a study by Bahrami et al, 3 was 5.80, indicating prominent tissue eosinophilia. Direct immunofluorescence studies revealed granular IgA ( Figure 3A ) and C3 ( Figure 3B ) staining of the vessel walls.
The patient was diagnosed with vesicular IgAV with prominent tissue eosinophilia. She discontinued oral cefdinir treatment and underwent intravenous prednisolone (2 mg/kg/d for 7 days, 1 mg/kg/d for 3 days and 0.5 mg/kg/d for 2 days), which promptly improved her abdominal pain and tarry stool, and her skin lesions completely disappeared 2 weeks later. Thereafter, she has experienced two episodes of nonvesicular purpura on the arms and legs 1 day following acute otitis media with oral cefditoren pivoxil treatment, and 2 days after upper respiratory tract infection without any drug usage, both of which subsided within 2 weeks without any medications. Urinalysis still remained normal 6 months after the onset of the illness on the latest outpatient examination.
| DISCUSSION
Our patient developed IgAV with blistering eruptions, while skin biopsy showed LCV of the small vessels in all the layers of the dermis with prominent tissue eosinophilia. Gration and Osakwe recently reported a case of a child with bullous IgAV whose skin biopsy showed pandermal LCV with tissue eosinophilia, histological findings similar to those of our patient. 4 Because LCV usually presents only in the superficial layer of the dermis in IgAV, activated neutrophils infiltrated the skin more extensively in our patient and in the patient of Gration and Osakwe. Blistering eruptions are rare in childhood IgAV, reported in only 1.5% of all patients. 2 However, they do not seem to have prognostic value, because they almost always spontaneously subside within 4 weeks. 2 The precise pathogenic mechanisms for the development of blistering eruptions in IgAV remain unclear; pressure or trauma, a pre-existing bullous condition, immunological dysregulation, and metalloproteinase (MMP)-9 and leukocyte elastase have been suggested as causes or triggers for this condition. 5 Kobayashi et al 6 reported that MMP-9 gelatinolytic activity was observed in the blister fluid of a patient with bullous IgAV, suggesting that MMP-9 derived from neutrophils might play an important role in blister formation. In this case, extensive infiltration of the skin by activated neutrophils may contribute to the development of blister formation in IgAV by MMP-9 secretion. Tissue eosinophilia is rare in childhood IgAV, 7 and it is not mentioned in most textbooks or review articles regarding childhood IgAV. 1, 8 In contrast, Poterucha et al 9 reported that 35 of 68 (51%) adult patients with IgAV had tissue eosinophilia, and patients with tissue eosinophilia were less likely to have renal involvement. This study included 1 patient with drug-induced IgAV and 11 patients with IgAV induced by infection and antibiotic use. Based on these findings, the authors suggested that tissue eosinophilia might be a marker of drug-induced IgAV in this study population. In addition, Bataille et al 10 reported a case of an adult patient with vancomycin-induced IgAV whose skin biopsies showed LCV with tissue eosinophilia Drug-induced vasculitis is the most common, accounting for about 20% of all cutaneous vasculitis. 11 13 Furthermore, blood and urinary LTB4 levels were higher in children with IgAV than those in healthy controls in the active phase. 14 Based on these findings, tissue eosinophilia may also develop in nondrug-induced IgAV due to LTB4 secreted by neutrophils which are activated by infections. In summary, we report a case of a child with IgAV who developed blistering eruptions. Extensive infiltration F I G U R E 3 Direct immunofluorescence of a skin biopsy shows granular IgA (A) and C3 (B) staining of the vessel walls of the skin by neutrophils which may be activated by infections or drug allergic reaction may have led to both blistering eruptions and tissue eosinophilia in our patient with IgAV.
